Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Hydrogen: a promising novel treatment for hepatic encephalopathy?

Qu J, Lü X.

Free Radic Biol Med. 2013 Oct;63:457-8. doi: 10.1016/j.freeradbiomed.2013.05.032. Epub 2013 Jun 3. No abstract available.

PMID:
23743290
2.

Ornithine phenylacetate revisited.

Jover-Cobos M, Noiret L, Sharifi Y, Jalan R.

Metab Brain Dis. 2013 Jun;28(2):327-31. doi: 10.1007/s11011-013-9391-5. Epub 2013 Mar 2. Review.

PMID:
23456516
3.

Hepatic encephalopathy: clinical aspects and pathogenetic concept.

Häussinger D, Sies H.

Arch Biochem Biophys. 2013 Aug 15;536(2):97-100. doi: 10.1016/j.abb.2013.04.013. Epub 2013 Apr 30. No abstract available.

PMID:
23643660
4.

Neurotoxicity of Ammonia.

Oja SS, Saransaari P, Korpi ER.

Neurochem Res. 2017 Mar;42(3):713-720. doi: 10.1007/s11064-016-2014-x. Epub 2016 Jul 28. Review.

PMID:
27465396
5.

Neurotransmitters and hepatic failure.

Fischer JE.

Conn Med. 1972 Oct;36(10):579-81. No abstract available.

PMID:
4404444
7.

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

Lockwood AH, Yap EW, Wong WH.

J Cereb Blood Flow Metab. 1991 Mar;11(2):337-41. Erratum in: J Cereb Blood Flow Metab 1992 Jan;12(1):177.

PMID:
1997506
8.

Pathogenesis and therapy of hepatic coma.

Fischer JE, Baldessarini RJ.

Prog Liver Dis. 1976;5:363-97. Review. No abstract available.

PMID:
5747
9.

Controversies in ammonia metabolism: implications for hepatic encephalopathy.

Lockwood AH.

Metab Brain Dis. 2007 Dec;22(3-4):285-9. No abstract available.

PMID:
17828448
10.

New strategies for treating hepatic encephalopathy.

Gómez-Gutiérrez C, Manzano-Robleda MC, Uribe M, Méndez-Sánchez N.

Ann Hepatol. 2014 May-Jun;13(3):409-11. No abstract available.

11.

Effects of lysine on ammonia formation, hydrogen ion, and potassium ion balance: a review and an hypothesis.

Zweig JI.

Clin Chem. 1973 Sep;19(9):943-9. Review. No abstract available.

PMID:
4598088
12.

Hepatic encephalopathy: current status.

Schenker S, Breen KJ, Hoyumpa AM Jr.

Gastroenterology. 1974 Jan;66(1):121-51. Review. No abstract available.

PMID:
4588556
13.

Hepatic encephalopathy.

[No authors listed]

N Engl J Med. 1986 Mar 20;314(12):784-7. No abstract available.

PMID:
3951510
14.

AMMONIA metabolism and hepatic coma.

[No authors listed]

Lancet. 1957 Mar 23;272(6969):623-4. No abstract available.

PMID:
13407086
15.

L-Carnitine in the treatment of mild or moderate hepatic encephalopathy.

Malaguarnera M, Pistone G, Astuto M, Dell'Arte S, Finocchiaro G, Lo Giudice E, Pennisi G.

Dig Dis. 2003;21(3):271-5.

PMID:
14571103
16.

[Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine].

De Caprio M, Carbone G, Cerotto GM, Corbosiero L, Vitale A.

Clin Ter. 1980 Mar 31;92(6):587-602. Italian. No abstract available.

PMID:
7460488
17.

Ammonia and hepatic encephalopathy: the more things change, the more they remain the same.

Shawcross DL, Olde Damink SW, Butterworth RF, Jalan R.

Metab Brain Dis. 2005 Sep;20(3):169-79. Review.

PMID:
16167195
18.

[Physiopathology of ammonia].

Attili AF, Cascino A, Rossi Fanelli F, Capocaccia L.

Recenti Prog Med. 1976 Sep;61(3):275-99. Review. Italian. No abstract available.

PMID:
798247
19.

The role of methanethiol in the pathogenesis of hepatic encephalopathy.

Blom HJ, Ferenci P, Grimm G, Yap SH, Tangerman A.

Hepatology. 1991 Mar;13(3):445-54.

PMID:
1999315
20.

Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy.

Görg B, Schliess F, Häussinger D.

Arch Biochem Biophys. 2013 Aug 15;536(2):158-63. doi: 10.1016/j.abb.2013.03.010. Epub 2013 Apr 6.

PMID:
23567841

Supplemental Content

Support Center